Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli

International Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages

  Batard, Eric ^a   Ollivier, Florence ^b   Boutoille, David ^a   Hardouin, Jean Benoît ^c   Montassier, Emmanuel ^a   Caillon, Jocelyne ^a   Ballereau, Françoise ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b Centre Medqual   (France)

^c Universite de Nantes   (France)

Author keywords

Cephalosporins; Escherichia coli; Quinolones; Resistance; Tetracyclines; Use

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; GLYCOPEPTIDE; IMIDAZOLE DERIVATIVE; LINCOSAMIDE; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLONE; QUINOLONE DERIVATIVE; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TICARCILLIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG USE; ESCHERICHIA COLI; HOSPITAL; HOSPITAL BED; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FRANCE; HOSPITALIZATION; HOSPITALS; HUMANS; QUINOLONES; REGRESSION ANALYSIS; TETRACYCLINES;

EID: 84875368699     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.10.005     Document Type: Article

References (15)

1. Stone S.P., Cooper B.S., Kibbler C.C., Cookson B.D., Roberts J.A., Medley G.F., et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007, 59:833-840.
2. Vernaz N., Huttner B., Muscionico D., Salomon J.L., Bonnabry P., Lopez-Lozano J.M., et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother 2011, 66:928-935.
3. Gallini A., Degris E., Desplas M., Bourrel R., Archambaud M., Montastruc J.L., et al. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. J Antimicrob Chemother 2010, 65:2650-2657.
4. Hsu L.Y., Tan T.Y., Tam V.H., Kwa A., Fisher D.A., Koh T.H. Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 2010, 54:1173-1178.
5. MacDougall C., Powell J.P., Johnson C.K., Edmond M.B., Polk R.E. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis 2005, 41:435-440.
6. Mahamat A., Lavigne J.P., Fabbro-Peray P., Kinowski J.M., Daures J.P., Sotto A. Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model. Clin Microbiol Infect 2005, 11:301-306.
7. Lai C.C., Wang C.Y., Chu C.C., Tan C.K., Lu C.L., Lee Y.C., et al. Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. J Antimicrob Chemother 2011, 66:1374-1382.
8. Lautenbach E., Strom B.L., Nachamkin I., Bilker W.B., Marr A.M., Larosa L.A., et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 2004, 38:655-662.
9. Pena C., Albareda J.M., Pallares R., Pujol M., Tubau F., Ariza J. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995, 39:520-524.
10. Hsueh P.R., Chen W.H., Luh K.T. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005, 26:463-472.
11. Kaier K., Frank U., Hagist C., Conrad A., Meyer E. The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis. J Antimicrob Chemother 2009, 63:609-614.
12. Nordmann P., Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005, 56:463-469.
13. Bruyere F., Cariou G., Boiteux J.P., Hoznek A., Mignard J.P., Escaravage L., et al. [Diagnosis, treatment and follow-up of community-acquired bacterial infections of the urinary system of men and women (acute cystitis and acute pyelonephritis) and of the genital system of men (acute prostatitis): general remarks]. Prog Urol 2008, 18(Suppl 1):4-8.
14. Gottesman B.S., Carmeli Y., Shitrit P., Chowers M. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009, 49:869-875.
15. Willemsen I., Cooper B., van Buitenen C., Winters M., Andriesse G., Kluytmans J. Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis. Antimicrob Agents Chemother 2010, 54:3763-3769.